Prognostic significance of serum cystatin c concentrations in renal transplant recipients: 5-year follow-up.
Leach
T D
TD
Wessex Renal & Transplant Unit St Mary's Hospital, Portsmouth, UK.
Kitiyakara
C
C
Price
C P
CP
Stevens
J M
JM
Newman
D J
DJ
D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D003404:Creatinine / Q000378:metabolism; D055316:Cystatin C; D015891:Cystatins / Q000097:blood*; D015853:Cysteine Proteinase Inhibitors / Q000097:blood*; D005260:Female; D005919:Glomerular Filtration Rate; D006801:Humans; D007674:Kidney Diseases / Q000145:classification / Q000601:surgery; D016030:Kidney Transplantation / Q000502:physiology*; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000145:classification*; D011184:Postoperative Period; D011237:Predictive Value of Tests; D011379:Prognosis; D012044:Regression Analysis; D017582:Renal Replacement Therapy; D016284:Technetium Tc 99m Pentetate; D013997:Time Factors; D016896:Treatment Outcome; D014517:Ureteral Obstruction / Q000453:epidemiology
D015415:Biomarkers; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; D003404:Creatinine; D016284:Technetium Tc 99m Pentetate